Related Experiment Video
Updated: May 1, 2026

In Vivo Mouse Model of Spinal Implant Infection
Published on: June 23, 2020
Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram
O Bargiacchi1, A Rossati, P Car
1Infectious Diseases Department, University Hospital "Maggiore della Carità", Novara, Italy, olivia.bargiacchi@gmail.com.
Abstract:
We report three cases of external ventricular derivation infections caused by multidrug-resistant Gram-negative rods and treated successfully with intraventricular colistin. The intrathecal or intraventricular use of colistin have been reported in more than 100 cases without any consensus on dosage, duration and type (monotherapy or combination therapy) of treatment. Based on our comprehensive review of the relevant literature relating to both clinical and pharmacokinetic data, we conclude that the intrathecal/intraventricular administration of colistin is a safe and effective option to treat central nervous system infections caused by multidrug-resistant Gram-negative bacteria.
Insights
Intraventricular colistin successfully treated three cases of external ventricular drain infections caused by multidrug-resistant Gram-negative rods. This approach is a safe and effective option for central nervous system infections.
Area of Science:
- Infectious Diseases
- Neurosurgery
- Pharmacology
Background:
- External ventricular drain (EVD) placement is crucial for managing various neurosurgical conditions.
- Infections associated with EVDs, particularly those caused by multidrug-resistant Gram-negative rods (MDR-GNRs), pose significant therapeutic challenges.
- Limited treatment options exist for MDR-GNR central nervous system (CNS) infections.
Related Concept Videos
Endocarditis III: Medical Management
Clinical Significance of Antibiotic Resistance
Endocarditis I: Introduction
Bacterial Meningitis I: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Bacterial Meningitis II: Pathophysiology

